Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.6
-5.88 %
$ 315 M
Market Cap
-2.39
P/E
ESPR - OTHER FINANCING ACTIVITIES
Other Financing Activities ESPR - Esperion Therapeutics, Inc.
-6.42 M
LAST VALUE
-6.28%
2 YEAR CAGR
-9.11%
5 YEAR CAGR
-0.70%
10 YEAR CAGR